Photon activation therapy and brachytherapy

Brachytherapy

Volumn 8, Issue 3, 2009, Pages 324-330

  Laster, Brenda H ^a   Dixon, Dabney W ^b   Novick, Sara ^a   Feldman, Jon P ^a   Seror, Veronique ^a   Goldbart, Zvi I ^a,c   Kalef Ezra, John A ^d  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b GEORGIA STATE UNIVERSITY   (United States)

^c NRCN Negev ^*  (Israel)

^d UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Auger electrons; Brachytherapy; Cancer; L absorption edge; Photoelectric absorption; Photoelectric effect; Platinum; Porphyrin; Radiation; TMPyP4

Indexed keywords

CELL DNA; PALLADIUM 103; PORPHYRIN DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRACHYTHERAPY; BREAST CARCINOMA; CANCER CELL; CANCER GROWTH; CONTROLLED STUDY; DOSIMETRY; IMPLANT; INTERMETHOD COMPARISON; MOUSE; NONHUMAN; PHOTON THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIOACTIVE SEED; X RAY;

ANIMALS; BRACHYTHERAPY; DNA, NEOPLASM; FEMALE; INTERCALATING AGENTS; MAMMARY NEOPLASMS, EXPERIMENTAL; METALLOPORPHYRINS; MICE; MICE, INBRED BALB C; ORGANOPLATINUM COMPOUNDS; PALLADIUM; PHOTONS; RADIOISOTOPES;

EID: 67651030081     PISSN: 15384721     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brachy.2008.12.008     Document Type: Article

References (41)

1. Santos M.R., Callisen H., Winter J., et al. Radiation dose enhancement in tumors with iodine. Med Phys 10 (1983) 75-78
2. Hofer K.G. Biophysical aspects of Auger processes: A review. Acta Oncol 35 (1996) 789-796
3. Hofer K.G. Biophysical aspects of Auger processes. Acta Oncol 39 (2000) 651-657
4. Adam J.F., Elleaume H., Joubert A., et al. Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: First trial on rats bearing F98 gliomas. Int J Radiat Oncol Biol Phys 57 (2003) 1413-1426
5. Hall E.J. Radiobiology for the radiologist. 5th ed. (2000), Lippincott Williams & Wilkins, Philadelphia
6. Fairchild R.G., and Bond V.P. Photon activation therapy. Strahlenther Onkol (1984) 758-763
7. Biston M.C., Joubert A., Adam J.F., et al. Cure of Fisher rats bearing radioresistant F98 glioma treated with cis-platinum and irradiated with monochromatic synchrotron X-rays. Cancer Res 64 (2004) 2317-2323
8. Le Sech C., Takakura K., Saint-Marc C., et al. Strand break induction by photoabsorption in DNA-bound molecules. Radiat Res 153 (2000) 454-458
9. Le Sech C., Takakura K., Saint-Marc C., et al. Enhanced strand break induction of DNA by resonant metal-innershell photoabsorption. Can J Physiol Pharmacol 79 (2001) 196-200
10. Maeda M., Kobayashi K., and Hieda K. Efficiencies of induction of DNA double strand breaks in solution by photoabsorption at phosphorus and platinum. Int J Radiat Biol 80 (2004) 841-847
11. Corde S., Balosso J., Elleaume H., et al. Synchrotron photoactivation of cisplatin elicits an extra number of DNA breaks that stimulate RAD51-mediated repair pathways. Cancer Res 63 (2003) 3221-3227
12. Corde S., Biston M.C., Elleaume H., et al. Lack of cell death enhancement after irradiation with monochromatic synchrotron X rays at the K-shell edge of platinum incorporated in living SQ20B human cells as cis-diamminedichloroplatinum (II). Radiat Res 158 (2002) 763-770
13. Kobayashi K., Frohlich H., Usami N., et al. Enhancement of X-ray-induced breaks in DNA bound to molecules containing platinum: A possible application to hadrontherapy. Radiat Res 157 (2002) 32-37
14. Kobayashi K., Frohlich H., Usami N., et al. Enhancement of X-ray-induced breaks in DNA bound to molecules containing platinum: a possible application to hadrontherapy. Radiat Res 157 (2002) 32-37
15. Pignol J.P., Rakovitch E., Beachey D., et al. Clinical significance of atomic inner shell ionization (ISI) and Auger cascade for radiosensitization using IUdR, BUdR, platinum salts, or gadolinium porphyrin compounds. Int J Radiat Oncol Biol Phys 55 (2003) 1082-1091
16. Usami N., Kobayashi K., Furusawa Y., et al. Irradiation of DNA loaded with platinum containing molecules by fast atomic ions C6+ and Fe26+. Int J Radiat Biol 83 (2007) 569-576
17. Rousseau J., Boudou C., Barth R.F., et al. Enhanced survival and cure of f98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clin Cancer Res 13 (2007) 5195-5201
18. Marzilli L.G. Medical aspects of DNA porphyrin interactions. New J Chem 140 (1990) 4090-4200
19. Pasternack R.F., and Gibbs E.J. Porphyrin and metalloporphyrin interactions with nucleic acids. Metal Ions Biol Syst 33 (1996) 367-397
20. Dixon D.W. Duplex DNA binding of nonplanar metal chelates of cationic porphyrins. In: Lee M., and Strekowski L. (Eds). Synthetic and biophysical studies of DNA binding compounds (2007), Singpost Press 239-262
21. Brown E., Firestone R.B., and Shirley V.S. Tables of radioactive isotopes (1986), John Wiley, New York
22. Rivard M.J., Coursey B.M., DeWerd L.A., et al. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations. Med Phys 31 (2004) 633-674
23. Howell R.W. Radiation spectra for Auger-electron emitting radionuclides: Report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 19 (1992) 1371-1383
24. Humm J.L., Howell R.W., and Rao D.V. Dosimetry of Auger-electron-emitting radionuclides: Report no. 3 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 21 (1994) 1901-1915
25. Rockwell S.C., Kallman R.F., and Fajardo L.F. Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative. J Natl Cancer Inst 49 (1972) 735-749
26. Rockwell S., and Kallman R.F. Cellular radiosensitivity and tumor radiation response in the EMT6 tumor cell system. Radiat Res 53 (1973) 281-294
27. Dixon D.W., Pu G.M., and Wojtowicz H. Capillary electrophoretic separation of cationic porphyrins. J Chromatogr A 802 (1998) 367-380
28. Barnes N.R., Schreiner A.F., and Dolan M.A. Measurement and interpretation of Q(0) and Q(1) band property changes of two cationic metalloporphyrins upon binding with B-DNA: Electronic MCD, CD, and optical absorption. J Inorg Biochem 72 (1998) 1-12
29. Dethlefsen L.A., Prewitt J.M., and Mendelsohn M.L. Analysis of tumor growth curves. J Natl Cancer Inst 40 (1968) 389-405
30. Peschel R.E., Colberg J.W., Chen Z., et al. Iodine-125 versus palladium-103 implants for prostate cancer: Clinical outcomes and complications. Cancer J 10 (2004) 170-174
31. 111In-labeled porphyrin for lymph node imaging. J Pharm Sci 71 (1982) 1223-1226
32. Foster N., Woo D.V., Kaltovich F., et al. Delineation of transplanted malignant melanoma with indium-111-labeled porphyrin. J Nucl Med 26 (1985) 756-760
33. Maric N., Chan S.M., Hoffer P.B., et al. Radiolabeled porphyrin vs gallium-67 citrate for the detection of human melanoma in athymic mice. Int J Rad Appl Instrum B 15 (1988) 543-551
34. Pasternack R.F., Brigandi R.A., Abrams M.J., et al. Interactions of porphyrins and metalloporphyrins with single-stranded poly(dA). Inorg Chem 29 (1990) 4483-4486
35. Izbicka E., Wheelhouse R.T., Raymond E., et al. Effects of cationic porphyrins as G-quadruplex interactive agents in human tumor cells. Cancer Res 59 (1999) 639-644
36. Shi D.F., Wheelhouse R.T., Sun D.Y., et al. Quadruplex-interactive agents as telomerase inhibitors: Synthesis of porphyrins and structure-activity relationship for the inhibition of telomerase. J Med Chem 44 (2001) 4509-4523
37. Baumstark-Khan C., Heilmann J., and Rink H. Induction and repair of DNA strand breaks in bovine lens epithelial cells after high LET irradiation. Adv Space Res 31 (2003) 1583-1591
38. Shin K.H., Kang M.K., Dicterow E., et al. Introduction of human telomerase reverse transcriptase to normal human fibroblasts enhances DNA repair capacity. Clin Cancer Res 10 (2004) 2551-2560
39. Wilt T.J., MacDonald R., Rutks I., et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 148 (2008) 435-438
40. Ding M., Newman F., and Raben D. New radiation therapy techniques for the treatment of head and neck cancer. Otolaryngol Clin North Am 38 (2005) 371-395
41. Grimard L., Esche B., Lamothe A., et al. Interstitial low-dose-rate brachytherapy in the treatment of recurrent head and neck malignancies. Head Neck 28 (2006) 888-895